CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 55212-55395 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T491","span":{"begin":0,"end":183},"obj":"Sentence"},{"id":"T33494","span":{"begin":0,"end":183},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The prevalence of PVL-positive CA-MRSA varies considerably from one continent to another (high for instance in the USA (~50%), Greece and Algeria, low in most European countries). vi."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T49","span":{"begin":0,"end":183},"obj":"Sentence"}],"text":"The prevalence of PVL-positive CA-MRSA varies considerably from one continent to another (high for instance in the USA (~50%), Greece and Algeria, low in most European countries). vi."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T139","span":{"begin":18,"end":21},"obj":"Disease"},{"id":"T140","span":{"begin":34,"end":38},"obj":"Disease"},{"id":"T72581","span":{"begin":18,"end":21},"obj":"Disease"},{"id":"T20857","span":{"begin":34,"end":38},"obj":"Disease"}],"attributes":[{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"},{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A50030","pred":"mondo_id","subj":"T72581","obj":"http://purl.obolibrary.org/obo/MONDO_0015742"},{"id":"A2520","pred":"mondo_id","subj":"T20857","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"The prevalence of PVL-positive CA-MRSA varies considerably from one continent to another (high for instance in the USA (~50%), Greece and Algeria, low in most European countries). vi."}